App Logo
DEEN
Start for free
BEST

Data Provider / Broker · B2B SaaS Provider · vs · B2B SaaS Provider

BeMyEye vs StrongPoint

Structured technology and market comparison · 2026

Direct Feature Comparison

BeMyEye · vs · StrongPoint
Market Cluster / Sector
BeMyEyeData Provider / Broker · B2B SaaS Provider
StrongPointB2B SaaS Provider
Platform Focus
BeMyEye

Retail execution software and crowdsourced in-store intelligence platform.

StrongPoint

Retail technology vendor for store operations, fulfilment and retail media.

Company Size
BeMyEye<10 employees
StrongPoint201–500 employees
Headquarters
BeMyEyeGB
StrongPointNO
Year Founded
BeMyEye2011
StrongPoint2002
Dossier & Alternatives

Analyze all overlapping signals and tech stacks for BeMyEye and StrongPoint

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare free in ExplorerFree · No credit card · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between BeMyEye and StrongPoint?

When comparing BeMyEye and StrongPoint, both platforms operate within the Measurement & Analytics Platform and B2B SaaS Provider ecosystem. BeMyEye is positioned as Retail execution software and crowdsourced in-store intelligence platform, whereas StrongPoint focuses on Retail technology vendor for store operations, fulfilment and retail media. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to BeMyEye and StrongPoint?

When evaluating BeMyEye and StrongPoint, enterprise buyers also consider other platforms in Measurement & Analytics Platform and B2B SaaS Provider. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of BeMyEye and StrongPoint compare?

BeMyEye is headquartered in GB (founded in 2011) with <10 employees. StrongPoint is based in NO (founded in 2002) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: BeMyEye vs StrongPoint

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

BE

BeMyEye

Recent Signals

No recent market signals documented for BeMyEye in the current tracking window.

View all signals for BeMyEye →
ST

StrongPoint

Recent Signals

  • ·StrongPoint

    Fast-Track Groceries: Morrisons Launches European Click & Collect Locker Technology in UK Supermarket First

    Morrisons launches European Click & Collect locker technology in UK supermarket first, a new press release on StrongPoint's news page.

  • ·SEC APIfinancials

    10-Q Financial Filing Analysis for StrongPoint

    Sutro Biopharma, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing the financial impacts of its ongoing corporate transition and pipeline reorientation. Total revenue decreased 85% year-over-year to $9.8 million from $63.7 million in Q2 2025, primarily driven by the termination of the STRO-003 collaboration with Ipsen and the resulting derecognition of deferred revenue. The company posted a net loss of $38.5 million for the quarter, mitigated in part by lower operating expenses following a two-thirds workforce reduction in 2025 and an externalized CDMO manufacturing model. Liquidity was bolstered earlier in the year via an underwritten public offering generating $110.0 million in gross proceeds to advance clinical assets STRO-004 and STRO-006, alongside a $10.0 million clinical milestone achieved from partner Astellas.

    • Q2 2026 revenue fell 85% year-over-year to $9.8 million (down from $63.7 million in Q2 2025) due to the termination of the Ipsen collaboration, resulting in a net loss of $38.5 million.
    • The company secured $110.0 million in gross proceeds via an underwritten public offering in February 2026 and recognized a $10.0 million Phase 1 clinical milestone from partner Astellas.
    • Operating structure reflects major 2025 cost-reduction initiatives, including a two-thirds workforce reduction and a transition to an outsourced CDMO manufacturing model.
View all signals for StrongPoint →

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners BeMyEye and StrongPoint share across the market ecosystem.

Start for freeBeMyEye ProfileStrongPoint Profile